US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Imalliance (MLIML) 銘柄情報

Imalliance (MLIML)

0.232

-0.028

(-10.77%)

終了 6月7日 12:30AM

Imalliance (MLIML) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.232

( -10.77% )

買値

0.23

売値

0.258

出来高

300

0.232 日の範囲 0.232

0.155 52 週間の範囲 0.40

時価総額

前日終値

0.26

始値

0.232

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

2,210 €

発行済株式数

4,472,279

配当利回り

PER

-0.98

1 株当たり利益 (EPS)

-0.27

歳入

3.48M

純利益

-452.94k

ImAlliance SA produces, manages, and distributes video and image media. The company operates an image platform covering the needs of the fixed and animated image chain, from production to distribution of all media types (photo, video, sound) using paper and web supports. ImAlliance SA combines media... ImAlliance SA produces, manages, and distributes video and image media. The company operates an image platform covering the needs of the fixed and animated image chain, from production to distribution of all media types (photo, video, sound) using paper and web supports. ImAlliance SA combines media production and exploitation technologies like film studio, film and video production, retouching and creative 3D services, publicity at multi-material points of sale, dynamic and 3D relief displays, media distribution and streaming video. ImAlliance SA was incorporated in 2002 and is based in Saint-Ouen, France. 詳細を表示

セクター

Media

業界

Traditional Media

ウェブサイト

www.imalliance.fr

本社

Saint-ouen, France

設立

2026

Imalliance is listed in the Media sector of the ユーロネクスト with ticker MLIML. The last closing price for Imalliance was 0.26 €. Over the last year, Imalliance shares have traded in a share price range of 0.155 € to 0.40 €.

Imalliance currently has 4,472,279 shares in issue. The market capitalisation of Imalliance is 1.04 € million. Imalliance has a price to earnings ratio (PE ratio) of -0.98.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.016	-6.45161290323	0.248	0.26	0.232	117	0.26	DE
4	0.032	16	0.2	0.26	0.18	141	0.20654159	DE
12	0.063	37.2781065089	0.169	0.272	0.155	569	0.19586125	DE
26	0.02	9.43396226415	0.212	0.4	0.155	995	0.25213806	DE
52	0.068	41.4634146341	0.164	0.4	0.155	837	0.23558805	DE
156	0.006	2.65486725664	0.226	0.675	0.155	1501	0.34735867	DE
260	0.052	28.8888888889	0.18	0.675	0.04	1299	0.32794991	DE

MLIML - Frequently Asked Questions (FAQ)

What is the current Imalliance share price?

The current share price of Imalliance is 0.232 €

How many Imalliance shares are in issue?

Imalliance has 4,472,279 shares in issue

What is the market cap of Imalliance?

The market capitalisation of Imalliance is EUR 1.04M

What is the 1 year trading range for Imalliance share price?

Imalliance has traded in the range of 0.155 € to 0.40 € during the past year

What is the PE ratio of Imalliance?

The price to earnings ratio of Imalliance is -0.98

What is the cash to sales ratio of Imalliance?

The cash to sales ratio of Imalliance is 0.33

What is the registered address of Imalliance?

The registered address for Imalliance is Cap St Ouen, Saint-Ouen, Ile-de-France, 93400

What is the Imalliance website address?

The website address for Imalliance is www.imalliance.fr

Which industry sector does Imalliance operate in?

Imalliance operates in the Traditional Media sector

Lve

What do you think the price will go to?

joe botts

joe botts 6分前

prowler3701

prowler3701 6分前

Are we still in the quiet period?? LOL!!

Are we still the game changing, jaw dropping, next Lionsgate, tentpole movie, myflix tail that wags the dog, unbelievable movie distributor lol.

17 years of failure buffoon boy CEO.

Jack Wagon CEO!!

richme

Guess there is the problem of numbers in the clientele realm??

flipper44

flipper44 7分前

It’s been half a year since the ASM. It’s been two decades since the phase iii trial appeared on clinicaltrials.gov.

It’s great they are all around the world advocating for cancer vaccines, but we need an update. We need approval.

MHRA/NWBO have taken long enough.

Lve

DewDiligence

DewDiligence 8分前

PFE Berobenatide—dosed monthly—appears to be competitive with Zepbound and Wegovy—dosed weekly—in terms of efficacy and tolerability—see slide 7 at the link in #msg-177679183.

US Market News

US Market News 8分前

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complicationsJune 6, 2026 2:30 PM
PR Newswire (US)

DewDiligence

DewDiligence 8分前

Berobenatide—dosed monthly—appears_ competitive_with_weekly Zepbound and Wegovy in_terms_of efficacy and tolerability—see slide 7 at the link in #msg-177679183.

janice shell

janice shell 8分前

It’s about time!!

GeorgSchreiberEU

GeorgSchreiberEU 12分前

Interesting development:

MSN has updated the name (not the ticker symbol) ... while OTC website still shows Natama

https://www.msn.com/en-us/money/stockdetails/fi-b19gfr?ocid=msedgntp&id=b19gfr

Rattlershehe

Rattlershehe 13分前

Well, 55 his to skinny. Sigma pharmaceuticals was not in our wheelhouse. As an advisor to the company, the easiest way that I could say is. The whole Sigma thing went south as soon as the books needed to be audited. They did not want anyone in their business.
Methylene blue came into the pic

brazen22

brazen22 14分前

The “as quickly as possible” versus “as many as possible” framing has a problem.

If someone had GBM 2.5 years ago, I doubt they would view delay as acceptable because it might help reach more patients later. For the current GBM population, the fastest path matters.

Appr

mascale

mascale 15分前

Qatar (royals) famous for recent lawful outcomes.

TightCoil

TightCoil 16分前

Pulte Related? or Not?
IC3: Industry Alerts
Safeguarding Our Secrets
https://www.ic3.gov/CSA/2026/260603.pdf
June 3, 2026
Full Press Release

________________________________________

Ssgiants89

Ssgiants89 18分前

Did anyone else catch the NBA championship game? I saw Jalen Brunson was wearing some type of venom gear to help with pain. I looked it up. It looks like it operates with heat and vibration. We need to send this man and actipatch!!

chumfm

chumfm 20分前

They are issuing millions of shares to cover their ATM.You will see upon completion a RS to move the price back to compliance.Check out CHR,same buyout,non-binding,and they formed a committee to look at the offer.Still no response and they already did a RS,after issuing millions of more shares.They

iateclube

iateclube 20分前

"The name and the material are called Liquidmetal' .... which Apple may or may not ever use. I agree with you though, they would probably want to use it even though Apple is funny about any outside name association. At the same time, liquidmetal is recognized as a generic substance. I suppose t

IhidfromtheX

IhidfromtheX 20分前

Well then in that case, we "should" be seeing revenue's! Are the sales going good in Europe?

peafunke

peafunke 20分前

https://dataintelo.com/report/concert-live-streaming-market
Always thought that was a bit high. Nevertheless sure. But that’s not how you debut an app and grow / retain users. Eventually it will be a piece of the pie.
Less go

Timing101

Timing101 22分前

$SRXH I have posted in some time, but holding strong and added this past week again . all good here. The DD is strong , not going by all the IMO (in my opinion) folks out there, just the facts, disclosures and potential.

trusttheman

trusttheman 22分前

Go Knicks and go Tptw!!!!! Suck it doubters!!!!

1manband

1manband 23分前

"We are tired of this nonsense"

There Are Millions of Crypto Tokens. Almost None Have Any Value

https://finance.yahoo.com/markets/crypto/articles/millions-crypto-tokens-almost-none-150000991.html

Charles Hoskinson is angry.

The founder of C

my3sons87

my3sons87 23分前

There are a few reasons why Simply Wall St articles about a company such as InterDigital can appear disproportionately negative, even when the underlying platform is not intentionally bearish.

My assessment is that the apparent negativity is more likely a consequence of rule-based and

magikalalpha

magikalalpha 24分前

https://x.com/DeborahHat96840/status/2063322755949273163?s=20

Abcourt Mines (QB)

JPMorgan BetaBuilders US...

West Fraser Timber

Activepassive US Equity ...

Trichome Financial

Minerva Gold (PK)

Amundi ETF ICAV

Farm Petr GNP PNB

Telephone and Data Systems

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。